Skip to content
Annalist
Companies Screener Compare Deal Lab Method Data Quality For AI agents

Gilead Sciences, Inc.

GILD · Nasdaq · Health care, biotechnology · United States · US GAAP · Fiscal year ends December

Latest report: Q3 FY2026, the quarter ended 30 September 2026, released 30 October 2026. Snapshot FY2026Q3_21f894d9.

Overview

Revenue, quarter
+6.8% year on year
Operating income, quarter
+4.1% year on year
Net income, quarter
−20.4% year on year
Diluted EPS, quarter
−20.2% year on year
Operating margin, last 4 quarters
−43.7pp year on year
Return on equity, last 4 quarters
−62.9pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest quarter, with their history over earlier quarters.

  1. Revenue for the quarter ended 30 September 2026 was US$8.3 billion, 6.8% higher than in the same quarter a year earlier.

    Weakenedin Q3 FY2026 · stated since Q2 FY20256.8% from 10.2% in Q2 FY2026
    Rule: Revenue against a year earlier · Sources 10-Q 2026-09
    History of this finding, 11 records
    1. Q3 FY2026 WeakenedRevenue for the quarter ended 30 September 2026 was US$8.3 billion, 6.8% higher than in the same quarter a year earlier.Recorded from FY2026Q3_21f894d9 · data update
    2. Q2 FY2026 StrengthenedRevenue for the quarter ended 30 June 2026 was US$7.8 billion, 10.2% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q1 FY2026 ConfirmedRevenue for the quarter ended 31 March 2026 was US$7.0 billion, 4.4% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q4 FY2025 StrengthenedRevenue for the quarter ended 31 December 2025 was US$7.9 billion, 4.7% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q3 FY2025 StrengthenedRevenue for the quarter ended 30 September 2025 was US$7.8 billion, 3.0% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q2 FY2025 NewRevenue for the quarter ended 30 June 2025 was US$7.1 billion, 1.8% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q2 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    8. Q1 FY2025 NewRevenue for the quarter ended 31 March 2025 was US$6.7 billion, 0.3% lower than in the same quarter a year earlier.Reconstructed · data update
    9. Q1 FY2025 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    10. Q4 FY2024 ConfirmedRevenue for the quarter ended 31 December 2024 was US$7.6 billion, 6.4% higher than in the same quarter a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewRevenue for the quarter ended 30 September 2024 was US$7.5 billion, 7.0% higher than in the same quarter a year earlier.Reconstructed · initial
  2. Net income attributable to the company was US$2.4 billion, 20.4% lower than in the same quarter a year earlier.

    Newin Q3 FY2026 · first stated
    Rule: Net income against a year earlier · Sources 10-Q 2026-09
    History of this finding, 14 records
    1. Q3 FY2026 NewNet income attributable to the company was US$2.4 billion, 20.4% lower than in the same quarter a year earlier.Recorded from FY2026Q3_21f894d9 · data update
    2. Q3 FY2026 RetiredThe finding changed to lower than a year earlier.Recorded from FY2026Q3_21f894d9 · data update
    3. Q2 FY2026 NewThe company reported a net loss of US$10.5 billion, against net income of US$2.0 billion in the same quarter a year earlier.Reconstructed · data update
    4. Q2 FY2026 RetiredThe finding changed to a loss.Reconstructed · data update
    5. Q1 FY2026 StrengthenedNet income attributable to the company was US$2.0 billion, 53.7% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q4 FY2025 WeakenedNet income attributable to the company was US$2.2 billion, 22.4% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q3 FY2025 StrengthenedNet income attributable to the company was US$3.1 billion, 143.6% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q2 FY2025 NewNet income attributable to the company was US$2.0 billion, 21.4% higher than in the same quarter a year earlier.Reconstructed · data update
    9. Q2 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    10. Q1 FY2025 NewNet income attributable to the company was US$1.3 billion, against a net loss of US$4.2 billion in the same quarter a year earlier.Reconstructed · data update
    11. Q1 FY2025 RetiredThe finding changed to a profit after a loss a year earlier.Reconstructed · data update
    12. Q4 FY2024 NewNet income attributable to the company was US$1.8 billion, 24.8% higher than in the same quarter a year earlier.Reconstructed · data update
    13. Q4 FY2024 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    14. Q3 FY2024 NewNet income attributable to the company was US$1.3 billion, 42.5% lower than in the same quarter a year earlier.Reconstructed · initial
  3. The operating margin over the last 4 quarters was -7.6%, 43.7 percentage points lower than a year earlier.

    Strengthenedin Q3 FY2026 · stated since Q2 FY2026
    Rule: Operating margin against a year earlier · Sources 10-K 2025-12, 10-Q 2025-09, 10-Q 2026-03 and 2 more
    History of this finding, 11 records
    1. Q3 FY2026 StrengthenedThe operating margin over the last 4 quarters was -7.6%, 43.7 percentage points lower than a year earlier.Recorded from FY2026Q3_21f894d9 · data update
    2. Q2 FY2026 NewThe operating margin over the last 4 quarters was -8.2%, 36.1 percentage points lower than a year earlier.Reconstructed · data update
    3. Q2 FY2026 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    4. Q1 FY2026 WeakenedThe operating margin over the last 4 quarters was 34.9%, 6.3 percentage points higher than a year earlier.Reconstructed · data update
    5. Q4 FY2025 WeakenedThe operating margin over the last 4 quarters was 34.0%, 28.3 percentage points higher than a year earlier.Reconstructed · data update
    6. Q3 FY2025 StrengthenedThe operating margin over the last 4 quarters was 36.1%, 33.2 percentage points higher than a year earlier.Reconstructed · data update
    7. Q2 FY2025 WeakenedThe operating margin over the last 4 quarters was 27.9%, 18.7 percentage points higher than a year earlier.Reconstructed · data update
    8. Q1 FY2025 NewThe operating margin over the last 4 quarters was 28.6%, 22.9 percentage points higher than a year earlier.Reconstructed · data update
    9. Q1 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    10. Q4 FY2024 WeakenedThe operating margin over the last 4 quarters was 5.8%, 22.3 percentage points lower than a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewThe operating margin over the last 4 quarters was 2.9%, 27.3 percentage points lower than a year earlier.Reconstructed · initial
  4. Return on equity over the last 4 quarters was -22.3%, against 40.5% a year earlier.

    Strengthenedin Q3 FY2026 · stated since Q2 FY2026
    Rule: Return on equity against a year earlier · Sources 10-Q 2025-09, 10-Q 2026-09, 10-K 2025-12 and 3 more
    History of this finding, 11 records
    1. Q3 FY2026 StrengthenedReturn on equity over the last 4 quarters was -22.3%, against 40.5% a year earlier.Recorded from FY2026Q3_21f894d9 · data update
    2. Q2 FY2026 NewReturn on equity over the last 4 quarters was -20.6%, against 33.3% a year earlier.Reconstructed · data update
    3. Q2 FY2026 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    4. Q1 FY2026 WeakenedReturn on equity over the last 4 quarters was 43.2%, against 32.5% a year earlier.Reconstructed · data update
    5. Q4 FY2025 WeakenedReturn on equity over the last 4 quarters was 40.5%, against 2.3% a year earlier.Reconstructed · data update
    6. Q3 FY2025 StrengthenedReturn on equity over the last 4 quarters was 40.5%, against 0.6% a year earlier.Reconstructed · data update
    7. Q2 FY2025 WeakenedReturn on equity over the last 4 quarters was 33.3%, against 5.3% a year earlier.Reconstructed · data update
    8. Q1 FY2025 NewReturn on equity over the last 4 quarters was 32.5%, against 2.5% a year earlier.Reconstructed · data update
    9. Q1 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    10. Q4 FY2024 WeakenedReturn on equity over the last 4 quarters was 2.3%, against 25.7% a year earlier.Reconstructed · data update
    11. Q3 FY2024 NewReturn on equity over the last 4 quarters was 0.6%, against 27.1% a year earlier.Reconstructed · initial
  5. Free cash flow over the last 4 quarters was US$13.8 billion, and operating cash flow was -3.7 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Strengthenedin Q3 FY2026 · stated since Q3 FY2024
    Rule: Free cash flow · Sources 10-K 2025-12, 10-Q 2025-09, 10-Q 2026-03 and 2 more
    History of this finding, 9 records
    1. Q3 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$13.8 billion, and operating cash flow was -3.7 times net income attributable to the company.Recorded from FY2026Q3_21f894d9 · data update
    2. Q2 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$12.9 billion, and operating cash flow was -4.2 times net income attributable to the company.Reconstructed · data update
    3. Q1 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$10.2 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    4. Q4 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$9.5 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    5. Q3 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$9.2 billion, and operating cash flow was 1.2 times net income attributable to the company.Reconstructed · data update
    6. Q2 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$9.4 billion, and operating cash flow was 1.6 times net income attributable to the company.Reconstructed · data update
    7. Q1 FY2025 ConfirmedFree cash flow over the last 4 quarters was US$9.8 billion, and operating cash flow was 1.7 times net income attributable to the company.Reconstructed · data update
    8. Q4 FY2024 StrengthenedFree cash flow over the last 4 quarters was US$10.3 billion, and operating cash flow was 22.6 times net income attributable to the company.Reconstructed · data update
    9. Q3 FY2024 NewFree cash flow over the last 4 quarters was US$9.4 billion, and operating cash flow was 79.5 times net income attributable to the company.Reconstructed · initial
  6. Net debt was US$19.8 billion at 30 September 2026, 43.8 times EBITDA over the last 4 quarters.

    Weakenedin Q3 FY2026 · stated since Q3 FY2024
    Rule: Net debt or net cash · Sources 10-Q 2026-09, 10-K 2025-12, 10-Q 2025-09 and 2 more
    History of this finding, 9 records
    1. Q3 FY2026 WeakenedNet debt was US$19.8 billion at 30 September 2026, 43.8 times EBITDA over the last 4 quarters.Recorded from FY2026Q3_21f894d9 · data update
    2. Q2 FY2026 StrengthenedNet debt was US$23.1 billion at 30 June 2026, 87.7 times EBITDA over the last 4 quarters.Reconstructed · data update
    3. Q1 FY2026 WeakenedNet debt was US$14.5 billion at 31 March 2026, 1.1 times EBITDA over the last 4 quarters.Reconstructed · data update
    4. Q4 FY2025 ConfirmedNet debt was US$17.3 billion at 31 December 2025, 1.4 times EBITDA over the last 4 quarters.Reconstructed · data update
    5. Q3 FY2025 WeakenedNet debt was US$17.6 billion at 30 September 2025, 1.3 times EBITDA over the last 4 quarters.Reconstructed · data update
    6. Q2 FY2025 StrengthenedNet debt was US$19.7 billion at 30 June 2025, 1.8 times EBITDA over the last 4 quarters.Reconstructed · data update
    7. Q1 FY2025 ConfirmedNet debt was US$17.0 billion at 31 March 2025, 1.5 times EBITDA over the last 4 quarters.Reconstructed · data update
    8. Q4 FY2024 WeakenedNet debt was US$16.7 billion at 31 December 2024, 3.8 times EBITDA over the last 4 quarters.Reconstructed · data update
    9. Q3 FY2024 NewNet debt was US$18.2 billion at 30 September 2024, 5.1 times EBITDA over the last 4 quarters.Reconstructed · initial

Records before Q3 FY2026 are reconstructed from the latest snapshot. Ledger: findings.json.

Credit, liquidity, earnings quality and score findings: Analysis.

Data

Source documents28 documents, latest Form 10-Q, period ended 30 September 2026List
DownloadsExcel workbook · JSON
SnapshotFY2026Q3_21f894d9

Corporate Events

  1. Acquisitions paid in cash31 December 2024

    Paid US$4.8 billion in cash for business acquisitions in fiscal 2024, 7.8% of total assets at the start of the year.

    Source 10-K 2025-12
  2. Acquisition23 October 2020

    Completed an acquisition.

    Source 8-K 2020-10

Earnings, Returns and Balance Sheet

Revenue

By quarter, US dollars

Operating Income

By quarter, US dollars

Net Income Attributable to the Company

By quarter, US dollars

Margins

Last 4 quarters at each quarter end, per cent

Returns

Last 4 quarters, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by quarter, US dollars

Net Debt

Total debt less cash and short-term investments, at quarter end, US dollars

Diluted Earnings per Share

By quarter, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a quarter derived from cumulative reports.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
Form 10-Q, period ended 30 September 202630 Oct 202610-Q:0000882095-26-000039
Form 10-Q, period ended 30 June 20266 Aug 202610-Q:0000882095-26-000031
Form 10-Q, period ended 31 March 20267 May 202610-Q:0000882095-26-000024
Form 10-K, period ended 31 December 202524 Feb 202610-K:0000882095-26-000006
Form 10-Q, period ended 30 September 20257 Nov 202510-Q:0000882095-25-000047
Form 10-Q, period ended 30 June 20257 Aug 202510-Q:0000882095-25-000032
Form 10-Q, period ended 31 March 20257 May 202510-Q:0000882095-25-000012
Form 10-K, period ended 31 December 202428 Feb 202510-K:0000882095-25-000006
Form 10-Q, period ended 30 September 202412 Nov 202410-Q:0000882095-24-000028
Form 10-Q, period ended 30 June 20248 Aug 202410-Q:0000882095-24-000022
Form 10-Q, period ended 31 March 20248 May 202410-Q:0000882095-24-000013
Form 10-K, period ended 31 December 202323 Feb 202410-K:0000882095-24-000007
Form 10-Q, period ended 30 September 20237 Nov 202310-Q:0000882095-23-000031
Form 10-Q, period ended 30 June 20234 Aug 202310-Q:0000882095-23-000025
Form 10-Q, period ended 31 March 20233 May 202310-Q:0000882095-23-000017
Form 10-K, period ended 31 December 202222 Feb 202310-K:0000882095-23-000007
Form 10-Q, period ended 30 September 20222 Nov 202210-Q:0000882095-22-000027
Form 10-Q, period ended 30 June 20228 Aug 202210-Q:0000882095-22-000019
Form 10-Q, period ended 31 March 20224 May 202210-Q:0000882095-22-000013
Form 10-K, period ended 31 December 202123 Feb 202210-K:0000882095-22-000007
Form 10-Q, period ended 30 September 20213 Nov 202110-Q:0000882095-21-000029
Form 10-Q, period ended 30 June 20215 Aug 202110-Q:0000882095-21-000021
Form 10-Q, period ended 31 March 20216 May 202110-Q:0000882095-21-000013
Form 10-K, period ended 31 December 202025 Feb 202110-K:0000882095-21-000008
Form 10-Q, period ended 30 September 20204 Nov 202010-Q:0000882095-20-000027
Form 8-K, period ended 23 October 202023 Oct 20208-K:0001104659-20-117765
Form 10-Q, period ended 30 June 20206 Aug 202010-Q:0000882095-20-000019
Form 10-Q, period ended 31 March 20206 May 202010-Q:0000882095-20-000013

Checks

300298 of 300 checks passed, 2 warnings
Fiscal calendar70 passedFiscal years last 350 to 380 days, quarters 80 to 125 days, and each period starts on the day after the one before. Checked at error level.
Quarters and fiscal year154 of 155 passedThe 4 quarters of every item add up to its fiscal year, or a later filing restated the year. Checked at error level; a difference that a later report explains is a warning, which does not stop publication.
Research and development expense, FY2020: $5,039m against $4,927m
Filer identity1 passedThe documents are those of the company of this page. Checked at error level.
Balance sheet identity27 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Lease liabilities6 passedLease payments due, less imputed interest, equal the lease liabilities. Checked at warning level.
Debt maturities1 passedThe debt maturity schedule adds up to the long-term debt. Checked at warning level.
Quarters and 9 months21 passedThe 3 reported quarters of a fiscal year add up to the reported 9-month figure. Checked at error level.
Gross profit0 of 1 passedRevenue less cost of revenue equals reported gross profit. Checked at warning level.
Q4 FY2020: 6,023,000,000 against 5,930,000,000
Earnings per share6 passedNet income divided by average shares agrees with reported basic earnings per share. Checked at warning level.
Interest and debt6 passedInterest expense of a fiscal year is between 0.5% and 15% of the average total debt at its opening and closing dates, so that the debt captured carries the interest reported. Checked at warning level.
Primary statements6 passedEach key figure of the latest fiscal year is a line of the income statement, the balance sheet or the cash flow statement of the annual report. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published1,612
Confirmed by other figures51.7%, 833 values
Confirmed by a second document0.0%, 0 values
Derived from reported figures23.0%, 370 values
Values withheld0
Restated figures tracked7
Changes compared on one basis0
Company lines mapped0 of 0 reviewed

Citation

Annalist, Gilead Sciences, Inc., snapshot gilead-sciences/FY2026Q3_21f894d9 (as of FY2026 Q3); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2026Q3_21f894d9 · dataset SHA-256 21f894d93e562ba3ab96fd02225bac8c11e7cbd1074425d2a2d15e7e39ee7c4a · findings rules 0.5

Data: info.json · dataset.json · validation.json · documents.json